Scaling-up Hepatitis Testing to Achieve the SDGs: Challenges and Opportunities from the COVID-19 Response

Scaling-up Hepatitis Testing to Achieve the SDGs: Challenges and Opportunities from the COVID-19 Response

September 28 2020
90 minutes
Webinar series
Hep Test
UNGA flier

This webinar brought together leading diagnostic organizations, country representatives, and public health institutions to discuss both the challenges and opportunities in hepatitis testing presented by COVID-19. 

Key discussion areas included:

  • Capacity building for diagnostic testing in response to COVID-19

  • The impact of COVID-19 on national capacity for hepatitis B and C testing

  • Opportunities for leveraging COVID-19 testing capacity to strengthen testing for hepatitis B and hepatitis C

Download the full program in the side bar.

 

This webinar was the first in a new webinar series called Hep Test that will bring together diverse stakeholders to:

1) share challenges and lessons learned in scaling-up HBV and HCV testing

2) build support for testing programs

3) disseminate innovations in testing technologies and strategies; and

4) identify new research needs.

Contact us at www.globalhep [at] taskforce.org

Dr. Catharina Boehme
CEO, Foundation for Innovative New Diagnostics (FIND)
Dr. Faisal Sultan
Special Assistant to the Prime Minister, Focal Point on Hepatitis Elimination, Government of Pakistan
Dr. Mengistu Erkie
Gastroentrologist, Addis Ababa University, President, Ethiopian Gastroenterology Association
Dr. Hanna Aberra
St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
Dr. Mohammed Abdulaziz
• Head of the Division of Disease Control, Africa Centres for Disease Control (Africa CDC), Addis Ababa, Ethiopia
Dr. Youngmee Jee
Special Representative for Health Diplomacy, Korea Foundation, Visiting Professor at the Graduate School of Public Administration, Seoul National University, Member, WHO International Health Regulation Emergency Committee on COVID-19